Andrea Zanichelli Selected Research

Acquired angioedema

8/2018	Splenic marginal zone lymphomas in acquired C1-inhibitor deficiency: clinical and molecular characterization.
9/2017	Diagnosis, Course, and Management of Angioedema in Patients With Acquired C1-Inhibitor Deficiency.
10/2016	Angioedema Phenotypes: Disease Expression and Classification.
4/2015	Treatment of ACEI-related angioedema with icatibant: a case series.
9/2013	Acquired C1-inhibitor deficiency and lymphoproliferative disorders: a tight relationship.
2/2013	Therapeutic options for patients with angioedema due to C1-inhibitor deficiencies: from pathophysiology to the clinic.
1/2013	Ecallantide for treatment of acute attacks of acquired C1 esterase inhibitor deficiency.
6/2011	Treatment of acquired angioedema with icatibant: a case report.
12/2010	Angioedema due to C1 inhibitor deficiency in 2010.
7/2010	Acquired angioedema.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Andrea Zanichelli Research Topics

Disease

35	Hereditary Angioedemas 03/2022 - 04/2002
22	Angioedema 01/2020 - 09/2002
10	Acquired angioedema 08/2018 - 07/2010
4	Rare Diseases (Rare Disease) 12/2019 - 09/2013
3	Edema (Dropsy) 01/2018 - 06/2008
2	Hereditary Angioedema Types I and II 01/2019 - 11/2018
1	Substance Withdrawal Syndrome (Withdrawal Symptoms) 01/2022
1	Hypersensitivity (Allergy) 04/2021
1	COVID-19 01/2020
1	Hereditary Complement Deficiency Diseases 01/2020
1	Anaphylaxis (Anaphylactic Shock) 01/2020
1	Emphysema 01/2020
1	Lung Diseases (Lung Disease) 01/2020
1	Pruritus (Itching) 01/2020
1	Urticaria (Hives) 01/2020
1	Chronic Obstructive Pulmonary Disease (COPD) 01/2020
1	Dizziness (Lightheadedness) 11/2018
1	Injection Site Reaction 11/2018
1	Overweight 01/2018
1	Body Weight (Weight, Body) 01/2018
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 09/2013
1	Paraproteinemias (Monoclonal Gammopathy) 09/2013
1	Nausea 06/2008
1	Abdominal Pain (Pain, Abdominal) 06/2008
1	Inborn Genetic Diseases (Disease, Hereditary) 06/2008
1	Infections 10/2006
1	Insect Bites and Stings (Insect Bite) 10/2006
1	Autoimmune Diseases (Autoimmune Disease) 10/2006

Drug/Important Bio-Agent (IBA)

13	BradykininIBA 01/2018 - 09/2002
12	icatibantIBA 01/2019 - 08/2010
7	Complement C1 Inhibitor Protein (C1 Esterase Inhibitor)IBA 04/2021 - 06/2008
6	Complement System Proteins (Complement)IBA 01/2020 - 07/2010
4	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 10/2016 - 10/2006
3	AndrogensIBA 01/2022 - 07/2010
3	lanadelumabIBA 01/2022 - 11/2018
3	Pharmaceutical PreparationsIBA 04/2021 - 10/2006
3	Plasma KallikreinIBA 11/2018 - 01/2013
3	Peptides (Polypeptides)IBA 09/2013 - 09/2002
2	Kininogens (Kininogen)IBA 01/2020 - 12/2017
2	Histamine (Histamine Dihydrochloride)FDA Link 01/2020 - 12/2016
2	Proteins (Proteins, Gene)FDA Link 01/2020 - 09/2002
2	Factor XII (Hageman Factor)IBA 01/2020 - 10/2016
2	KininsIBA 12/2019 - 07/2010
2	AutoantibodiesIBA 09/2013 - 09/2002
2	Antifibrinolytic Agents (Antifibrinolytics)IBA 02/2013 - 07/2010
2	ecallantide FDA Link 01/2013 - 06/2008
1	Complement C1 (Complement 1)IBA 08/2021
1	A-factor (Streptomyces)IBA 01/2020
1	PlasminogenIBA 01/2020
1	Angiopoietin-1IBA 01/2020
1	Complement Inactivating AgentsIBA 01/2020
1	Monoclonal AntibodiesIBA 11/2018
1	Kallikreins (Kallikrein)IBA 01/2018
1	acivicin (AT 125)IBA 01/2018
1	Secretory Phospholipases A2IBA 01/2018
1	berotralstatIBA 01/2018
1	Biomarkers (Surrogate Marker)IBA 12/2017
1	AntigensIBA 09/2017
1	Bradykinin B2 ReceptorIBA 09/2015
1	AntibodiesIBA 09/2013
1	Antihypertensive Agents (Antihypertensives)IBA 11/2011
1	Histamine Antagonists (Antihistamines)IBA 12/2010
1	Tranexamic Acid (AMCA)FDA Link 08/2010
1	Bradykinin Receptor AntagonistsIBA 08/2010
1	Capsules (Microcapsules)IBA 06/2008
1	Hormones (Hormone)IBA 09/2004
1	Anticardiolipin AntibodiesIBA 04/2002

Therapy/Procedure

13	Therapeutics 03/2022 - 02/2009
2	Self Administration (Administration, Self) 01/2020 - 10/2018
1	Dental Care 01/2020
1	Exercise Therapy (Therapy, Exercise) 01/2020
1	Oral Administration 01/2018